Inhibition of ERK and p38 MAP kinases inhibits binding of Nrf2 and induction of GCS genes

LM Zipper, RT Mulcahy - Biochemical and biophysical research …, 2000 - Elsevier
LM Zipper, RT Mulcahy
Biochemical and biophysical research communications, 2000Elsevier
Genes encoding the catalytic (GCSh) and regulatory (GCSl) subunits of human γ-
glutamylcysteine synthetase (γGCS), which catalyzes the rate limiting step in glutathione
synthesis, are up-regulated in response to xenobiotics through Electrophile Response
Elements (EpREs). Exposure of HepG2 cells to the GCS-inducing agent, Pyrrolidine
dithiocarbamate (PDTC), results in ERK and p38 MAP kinase activation. Inhibition of ERK or
p38 kinases by PD98059 or SB202190, respectively, results in∼ 50% reduction in GCS …
Genes encoding the catalytic (GCSh) and regulatory (GCSl) subunits of human γ-glutamylcysteine synthetase (γGCS), which catalyzes the rate limiting step in glutathione synthesis, are up-regulated in response to xenobiotics through Electrophile Response Elements (EpREs). Exposure of HepG2 cells to the GCS-inducing agent, Pyrrolidine dithiocarbamate (PDTC), results in ERK and p38 MAP kinase activation. Inhibition of ERK or p38 kinases by PD98059 or SB202190, respectively, results in ∼50% reduction in GCS gene induction, while simultaneous inhibition completely eliminates induction. Induction of GCS expression is associated with an increase in Nrf2 and JunD binding to GCS EpREs. Pretreatment with the MAPK inhibitors significantly reduces binding of both transcription factors. These studies indicate that ERK and p38 contribute to the transcriptional up-regulation of the GCS subunit genes following PDTC treatment. Furthermore, supershift analyses suggest that binding of Nrf2 and JunD to the EpRE is a downstream consequence of ERK and p38 phosphorylation events.
Elsevier